Bullboard - Stock Discussion Forum Avivagen Inc VIVXF

Healthcare

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

Add To Watchlist

GREY:VIVXF - Post Discussion

Avivagen Inc > could be a fairly fast launch with no drug approvals req

View:

Post by StoneMan45 on Mar 21, 2020 10:11am

could be a fairly fast launch with no drug approvals req

Avivagen Inc. (TSXV:VIV) (“Avivagen”), a life sciences corporation focused on developing and commercializing products that safely support immune function and dampen inflammation, thereby supporting general health and well-being, announces today that it is accelerating its plans for commercial launch of its OxC-Beta product as a supplement for human use in response to the COVID-19 pandemic. OxC-beta is a patent protected product that first launched commercially in livestock applications to help remove antibiotics as growth promoters from the food chain, subsequently launched in the companion animal market as a supplement and is now being readied to launch in the US market, initially, for human use as a health supplement. We will provide updates through additional press releases as the product gets closer to an official commercial launch date and product availability.

page 20.
'No drug app[rovals required'
'Natural product category similar to Omega-3'
https://www.avivagen.com/wp-content/uploads/2020AlphaNorth-Conference.pdf
https://web.tmxmoney.com/article.php?newsid=7189422301857066&qm_symbol=VIV

165